A single-centre, retrospective study of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer
Latest Information Update: 21 Jan 2021
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 21 Jan 2021 New trial record